Activated Local Immunity by CC Chemokine Ligand 19-Transduced Embryonic Endothelial Progenitor Cells Suppresses Metastasis of Murine Ovarian Cancer
Open Access
- 12 November 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 28 (1) , 164-173
Abstract
Although tumor microenvironments play a key role in successful tumor immunotherapy, effective manipulation of local immunity is difficult because of the lack of an appropriate target system. It is well known that bone marrow-derived endothelial progenitor cells (EPCs) are actively recruited during tumor angiogenesis. Using this feature, we attempted to establish a novel therapeutic modality that targets tumor vessels of multiple metastases using embryonic endothelial progenitor cells (eEPCs) transduced with an immune-activating gene. The eEPCs were retrovirally transduced with the mouse CC chemokine ligand 19 (CCL19) gene, a lymphocyte-migrating chemokine. The mouse ovarian cancer cell line OV2944-HM-1 (HM-1) was inoculated subcutaneously into B6C3F1 mice, along with CCL19-tranduced eEPCs (eEPC-CCL19), resulting in immunologic activity and tumor-inhibitory effects. In this model, eEPC-CCL19 showed tumor repression accompanied by increased tumor-infiltrating CD8+ lymphocytes compared with the control group. In contrast, no tumor repression was observed when the same experiment was done in immunodeficient (SCID) mice, suggesting a crucial role of T-cell function in this system. Next, we established a lung metastasis model by injecting HM-1 cells or B16 melanoma cells via the tail vein. Subsequent intravenous injection of eEPC-CCL19 leads to a decrease in the number of lung metastasis and prolonged survival. Antitumor effects were also observed in a peritoneal dissemination model using HM-1. These results suggest that systemic delivery of an immune-activating signal using EPCs can alter the tumor immune microenvironment and lead to a therapeutic effect, which may provide a novel strategy for targeting multiple metastases of various malignancies.Keywords
Funding Information
- Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology of Japan (19591932, 18209052, 19659421)
This publication has 44 references indexed in Scilit:
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Immunotherapy of cancer by IL-12-based cytokine combinationsExpert Opinion on Biological Therapy, 2007
- Immunologic Approaches to Ovarian Cancer TreatmentJournal of Clinical Oncology, 2007
- Endothelial progenitor cells as therapeutic vectors in cardiovascular disorders: From experimental models to human trialsPharmacology & Therapeutics, 2007
- Immunosuppressive Strategies that are Mediated by Tumor CellsAnnual Review of Immunology, 2007
- Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+T lymphocytes are prognostic factors of human ovarian cancerProceedings of the National Academy of Sciences, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Local Delivery of Vaccinia Virus Expressing Multiple Costimulatory Molecules for the Treatment of Established TumorsHuman Gene Therapy, 2006
- Inhibition of Growth and Metastasis of Ovarian Carcinoma by Administering a Drug Capable of Interfering with Vascular Endothelial Growth Factor ActivityJapanese Journal of Cancer Research, 1996
- Unstable Expression of E‐Cadherin Adhesion Molecules in Metastatic Ovarian Tumor CellsJapanese Journal of Cancer Research, 1989